For more on the moves, Missouo healthcare strategist Jared Holes joins us here on set. Jared, great to have you with us. It felt like the bar was sort of low when it comes to Novo and the Alzheimer's data and yet the stock is moving this much lower.I mean, what what do you need to see at this point. What do I mean, is it a value trap here. I >> think you just need to see some resurrection of of its obesity drug in terms of revenue, right.Like it's hard to believe we're at four to five year lows with in the ...

Welcome to the sardine challenge. So, the only thing on the menu for the next 3 days is sardines. I challenge you to try and eat three of those cans in a day because that's a hell of a tool to help you get into a ketogenic state. And when you're in a ketogenic state, it helps burn fat.Muscle mass gets higher preserved. I've seen patients that have reversed their gray hair and that brain performance, concentration, and energy. All of those things improve.Sorry, the sardine juice has gone on my iPad. >> Good ...

Meanwhile, take a look at shares of Novo today falling to a four-year low this morning after results from its highly anticipated Alzheimer's drug trial failed to meet its main goal. The trial showed Novo's weight loss drug MGovi did not slow the progression of Alzheimer's. Joining us with some reaction today, city's head of US Pharma and biotech research Jeff Meum is with us.Jeff, thanks for the time. Good to see you again. >> Yeah, you too, Carl.Thank you for having me. >> I've seen the phrase longshot ass ...

Welcome to the sardine challenge. So, the only thing on the menu for the next 3 days is sardines. I challenge you to try and eat three of those cans in a day because that's a hell of a tool to [music] help you get into a ketogenic state. And when you're in a ketogenic state, it helps burn fat, muscle mass [music] gets higher, preserved. I've seen patients that have reversed their gray hair and that brain performance, concentration, and energy. All of those things improve. And so, I'm going to teach you how ...

How can you determine short of an autopsy if you have amalloid in your brain. >> So uh in the past when I was in medical school eons ago uh that was the only way. Today it's a simple blood test through the vein through a finger prick.We can detect amaloid and tow and in our lab we detect hundreds of proteins, hundreds of brain proteins uh just from the. ...

So the best way to summarize to prevent getting Alzheimer's if you can quote prevent it would be to do what >> the thing that I advocate for is to get educated and get informed. There are so many free resources out there. We did a a randomized controlled NIH funded trial through the comfort of your own cell phone can do a risk assessment can do a cognitive test and then the software can tell the person what to do to reduce their risk.Sleep is critical. Um, you know, you can exercise all you want, but if you ...

"I think it was super important to rectify the narrative around Alzheimer's which didn't have women in the narrative."Maria Shriver, founder of The Women's Alzheimer's Movement, spoke about why she's advocating for women's brain research. #ForbesOver50https://t.co/utEODMUAoB https://t.co/USkTFwS1Gr ...

Women's Health Advocacy - The Women's Alzheimer's Movement advocates for research on women's brain health [1] - Maria Shriver, founder of The Women's Alzheimer's Movement, is actively using her voice to promote this cause [1] Media Mention - Forbes Women Editor interviewed Maria Shriver [1]

"I'm using my voice the best I can."Maria Shriver, founder of The Women's Alzheimer's Movement, spoke to Forbes Women Editor @mcgrathmag about advocating for research on women's brain health. #ForbesOver50Read more: https://t.co/utEODMUAoB https://t.co/qGhb0oYzeD ...

Alzheimer's Research Advocacy - The Women's Alzheimer's Movement advocates for women's brain research [1] - The movement aims to rectify the narrative around Alzheimer's, which previously lacked focus on women [1] Media Mention - Maria Shriver, founder of The Women's Alzheimer's Movement, was featured in ForbesOver50 [1]